Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
39.35
70.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co Ltd
Selling, General & Administrative
Yunnan Botanee Bio-Technology Group Co Ltd
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Selling, General & Administrative
-¥3B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Selling, General & Administrative
-¥5.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
|
|
S
|
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
|
Selling, General & Administrative
-¥1.7B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Selling, General & Administrative
-¥5.4B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Selling, General & Administrative
-¥4.3B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Selling, General & Administrative
-¥1.3B
|
CAGR 3-Years
-87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
Glance View
In the lush landscape of China's Yunnan province, Yunnan Botanee Bio-Technology Group Co Ltd has emerged as a formidable player in the skincare and beauty industry. This company, with its roots deeply intertwined with the rich biodiversity of the region, focuses on harnessing the natural bounty of botanicals to develop innovative skincare solutions. Their expertise lies in transforming these local plant resources into high-value products, capitalizing on the growing global demand for natural and organic ingredients. Each product is a testament to the company's commitment to sustainability and scientific innovation, appealing to a modern consumer base increasingly conscious about the origins and effectiveness of their skincare products. The company’s business model effectively capitalizes on both upstream and downstream processes in the beauty value chain. By controlling the entire journey from plant cultivation to product formulation and final marketing, Yunnan Botanee ensures quality and authenticity at every stage. Their flagship brand, Winona, has carved out a niche in the sensitive skin category, leveraging cutting-edge dermatological research and traditional Chinese herbal knowledge. This strategic positioning, along with strong direct-to-consumer sales combined with an omnichannel retail strategy, bolsters its revenue streams and enhances brand loyalty. Through this integrated approach, the company not only rides the wave of clean beauty trends but also sets a benchmark for sustainable growth in the industry.
See Also
What is Yunnan Botanee Bio-Technology Group Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-3B
CNY
Based on the financial report for Dec 31, 2023, Yunnan Botanee Bio-Technology Group Co Ltd's Selling, General & Administrative amounts to -3B CNY.
What is Yunnan Botanee Bio-Technology Group Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-37%
Over the last year, the Selling, General & Administrative growth was -27%. The average annual Selling, General & Administrative growth rates for Yunnan Botanee Bio-Technology Group Co Ltd have been -33% over the past three years , -37% over the past five years .
You don't have any saved screeners yet
